Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy Metabolism.

Feigenson M, Eliseev RA, Jonason JH, Mills BN, O'Keefe RJ.

J Cell Biochem. 2017 Dec;118(12):4383-4393. doi: 10.1002/jcb.26092. Epub 2017 May 31.

2.

Effect of leptin combined with CoCl2 on healing in Sprague Dawley Rat fracture model.

Liu P, Liu J, Xia K, Chen L, Wu X.

Sci Rep. 2016 Jul 29;6:30754. doi: 10.1038/srep30754.

3.

Hif1α is required for osteoclast activation and bone loss in male osteoporosis.

Tando T, Sato Y, Miyamoto K, Morita M, Kobayashi T, Funayama A, Kanaji A, Hao W, Watanabe R, Oike T, Nakamura M, Matsumoto M, Toyama Y, Miyamoto T.

Biochem Biophys Res Commun. 2016 Feb 5;470(2):391-396. doi: 10.1016/j.bbrc.2016.01.033. Epub 2016 Jan 11.

PMID:
26792721
4.

Mechanism Underlying Post-menopausal Osteoporosis: HIF1α is Required for Osteoclast Activation by Estrogen Deficiency.

Miyamoto T.

Keio J Med. 2015;64(3):44-7. doi: 10.2302/kjm.2015-0003-RE. Epub 2015 Aug 8. Review.

5.

HIF-1α-induced microRNA-210 reduces hypoxia-induced osteoblast MG-63 cell apoptosis.

Sun G, Peng H.

Biosci Biotechnol Biochem. 2015;79(8):1232-9. doi: 10.1080/09168451.2014.1003128. Epub 2015 Jun 3.

PMID:
26037388
6.

HIF-1α change in serum and callus during fracture healing in ovariectomized mice.

Li W, Wang K, Liu Z, Ding W.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):117-26. eCollection 2015.

7.

Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone.

Kusumbe AP, Ramasamy SK, Adams RH.

Nature. 2014 Mar 20;507(7492):323-328. doi: 10.1038/nature13145. Epub 2014 Mar 12. Erratum in: Nature. 2014 Sep 25;513(7519):574.

8.

Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α).

Zhao G, Liu Y, Fang J, Chen Y, Li H, Gao K.

Biochem Biophys Res Commun. 2014 Jun 6;448(3):303-7. doi: 10.1016/j.bbrc.2014.02.062. Epub 2014 Feb 22.

PMID:
24569076
9.

Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential.

Ding H, Gao YS, Wang Y, Hu C, Sun Y, Zhang C.

Stem Cells Dev. 2014 May 1;23(9):990-1000. doi: 10.1089/scd.2013.0486. Epub 2014 Jan 24.

10.

Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity.

Liu X, Tu Y, Zhang L, Qi J, Ma T, Deng L.

Cell Biochem Biophys. 2014 May;69(1):141-9. doi: 10.1007/s12013-013-9780-8.

PMID:
24242187
11.

Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner.

Wagegg M, Gaber T, Lohanatha FL, Hahne M, Strehl C, Fangradt M, Tran CL, Schönbeck K, Hoff P, Ode A, Perka C, Duda GN, Buttgereit F.

PLoS One. 2012;7(9):e46483. doi: 10.1371/journal.pone.0046483. Epub 2012 Sep 27.

12.

Hypoxic downregulation of cellular proliferation and loss of phenotype stability in human osteoblasts is mediated by HIF-1α.

Lechler P, Klein SM, Prantl L, Englert C, Renkawitz T, Grifka J.

Clin Hemorheol Microcirc. 2011;49(1-4):279-86. doi: 10.3233/CH-2011-1478.

PMID:
22214699
13.

Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST.

Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC.

PLoS One. 2011;6(9):e23965. doi: 10.1371/journal.pone.0023965. Epub 2011 Sep 9.

14.

Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas.

Hoff P, Gaber T, Schmidt-Bleek K, Sentürk U, Tran CL, Blankenstein K, Lütkecosmann S, Bredahl J, Schüler HJ, Simon P, Wassilew G, Unterhauser F, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Immunol Res. 2011 Oct;51(1):116-22. doi: 10.1007/s12026-011-8235-9.

PMID:
21720875
15.

Human early fracture hematoma is characterized by inflammation and hypoxia.

Kolar P, Gaber T, Perka C, Duda GN, Buttgereit F.

Clin Orthop Relat Res. 2011 Nov;469(11):3118-26. doi: 10.1007/s11999-011-1865-3.

16.

Hypoxia stimulates osteoclast formation from human peripheral blood.

Utting JC, Flanagan AM, Brandao-Burch A, Orriss IR, Arnett TR.

Cell Biochem Funct. 2010 Jul;28(5):374-80. doi: 10.1002/cbf.1660.

PMID:
20556743
17.

[Expression of hypoxia-inducible factor-1alpha and matrix metalloproteinase-2 in degenerative lumbar intervertebral disc].

Wu WP, Jiang JM, Qu DB, Wei QZ, Jiang H.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):1152-5. Chinese.

PMID:
20501419
18.

Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair.

Nagano M, Kimura K, Yamashita T, Ohneda K, Nozawa D, Hamada H, Yoshikawa H, Ochiai N, Ohneda O.

Stem Cells Dev. 2010 Aug;19(8):1195-210. doi: 10.1089/scd.2009.0447.

PMID:
20345248
19.

Healing of non-displaced fractures produced by fatigue loading of the mouse ulna.

Martinez MD, Schmid GJ, McKenzie JA, Ornitz DM, Silva MJ.

Bone. 2010 Jun;46(6):1604-12. doi: 10.1016/j.bone.2010.02.030. Epub 2010 Mar 6.

20.

Prostaglandin expression profile in hypoxic osteoblastic cells.

Lee CM, Genetos DC, Wong A, Yellowley CE.

J Bone Miner Metab. 2010;28(1):8-16. doi: 10.1007/s00774-009-0096-0. Epub 2009 May 28.

PMID:
19471853

Supplemental Content

Loading ...
Support Center